GlassScriptPhysician profile
Nidhi Agarwal
NPI 1518387125
$1,669.33
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
See the full distribution for Endocrinology, Diabetes & Metabolism
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $172 · 2020: $377 · 2021: $675 · 2022: $390 · 2024: $55.50.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $55.50.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $55.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $478.19 | 2019-2022 | |
| Novo Nordisk INC | $367.25 | 2019-2022 | |
| Amgen INC. | $148.28 | 2020-2024 | Repatha |
| Sanofi-Aventis U.S. LLC | $115.65 | 2019-2022 | |
| Medtronic, INC. | $92.85 | 2021 | |
| Insulet Corporation | $92.60 | 2021 | |
| Zealand Pharma US, INC. | $54.52 | 2021 | |
| Dexcom, INC. | $53.94 | 2021-2022 | |
| Medtronic Minimed, INC. | $36.28 | 2020 | |
| Xeris Pharmaceuticals, INC. | $34.36 | 2021 | |
| Corcept Therapeutics | $34.00 | 2021-2022 | |
| Ascensia Diabetes Care US INC. | $27.44 | 2021 | |
| Abbvie INC. | $26.47 | 2021 | |
| Janssen Pharmaceuticals, INC | $24.91 | 2019 | |
| Mannkind Corporation | $20.62 | 2022 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Horizon Therapeutics Plc | $18.00 | 2019 | |
| Merck Sharp & Dohme LLC | $16.41 | 2020 | |
| Tandem Diabetes Care, INC. | $13.95 | 2019 | |
| Vistapharm, INC. | $13.61 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nidhi Agarwal listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.